Symbols / VIRI
VIRI Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2024-11-07 07:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- Assessing Whether Viridien Société Anonyme (ENXTPA:VIRI) Looks Overvalued After Strong Recent Share Price Momentum - Yahoo Finance ue, 13 Jan 2026 08
- Viridien (ENXTPA:VIRI): Profit Forecasts Test Investor Optimism as Revenue Trails Market Growth - simplywall.st Sat, 01 Nov 2025 07
- Viridien stock soars 24% after Q3 earnings top forecasts on Earth Data boost - Investing.com Fri, 31 Oct 2025 07
- Viridien (CGG) Appoints Henning Berg as Group CEO from 2026, Sophie Zurquiyah to Chair - Stock Titan Wed, 19 Nov 2025 08
- Viridien (ENXTPA:VIRI) Losses Narrow Rapidly as Path to Profit Challenges Market Growth Expectations - Yahoo Finance Sat, 01 Nov 2025 07
- Switching From Avastin to Bevacizumab-bvzr in CRC, NSCLC Can Reduce Medicare Costs - Center for Biosimilars Sat, 10 May 2025 07
- VIRI: 2025 revenue exceeded $1,150 million, with robust cash flow and major debt reduction - TradingView Mon, 12 Jan 2026 08
- The Truth About Virios Therapeutics (VIRI): Tiny Biotech, Massive Hype – But Is It Worth Your Mone - AD HOC NEWS hu, 05 Feb 2026 08
- Bernstein downgrades Viridien stock rating despite raising price target - Investing.com Fri, 21 Nov 2025 08
- Viridien (CGG) begins 4,300 sq km Angola block 22 reimaging to support licensing round - Stock Titan Wed, 10 Dec 2025 08
- Learning From Past Innovations to Advance Ventilation Use in Respiratory Conditions - AJMC ue, 21 May 2024 07
- Earnings call transcript: Viridien Q3 2025 sees strong revenue growth and stock uptick - Investing.com hu, 30 Oct 2025 07
- Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. to Combine to Form Dogwood Therapeutics, Inc. - orrick.com Mon, 07 Oct 2024 07
- AQ Podcast | Mexico: Claudia Sheinbaum’s Moment - Americas Quarterly hu, 20 Mar 2025 07
- Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. - GlobeNewswire Mon, 07 Oct 2024 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for VIRI
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|